A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia

NCT00236821 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

530

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia

Interventions

DRUG: levofloxacin

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]